CURRENT AFFAIRS (2 MAY 2024)

CURRENT AFFAIRS (2 MAY 2024)

LAW AND GOVERNANCE  AstraZeneca’s Vaccine and India’s Response AstraZeneca’s acknowledgment of rare blood clotting risks associated with its COVID-19 vaccine, known as Covishield in India, has stirred concern among recipients. While some fear the...